prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics
novartis vaccines and diagnostics s.r.l. - yfirborðs mótefna gegn inflúensuveiru (haemagglutinin og neuraminidasa) á stofn a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - bóluefni - virkt bólusetning gegn h5n1 undirgerð inflúensu a veiru. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.
oxycontin depot (oxycontin) forðatafla 10 mg
mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 10 mg
oxycontin depot forðatafla 20 mg
mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 20 mg
oxycontin depot forðatafla 40 mg
mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 40 mg
oxycontin depot forðatafla 5 mg
mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 5 mg
oxycontin depot forðatafla 80 mg
mundipharma a/s - oxycodonum hýdróklóríð - forðatafla - 80 mg
oxikodon depot actavis forðatafla 20 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 20 mg
oxikodon depot actavis forðatafla 40 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 40 mg
oxikodon depot actavis forðatafla 10 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 10 mg
oxikodon depot actavis forðatafla 5 mg
actavis group ptc ehf. - oxycodonum hýdróklóríð - forðatafla - 5 mg